- Home
- Publications
- Publication Search
- Publication Details
Title
Tumor immune checkpoints and their associated inhibitors
Authors
Keywords
-
Journal
Journal of Zhejiang University-SCIENCE B
Volume 23, Issue 10, Pages 823-843
Publisher
Zhejiang University Press
Online
2022-10-17
DOI
10.1631/jzus.b2200195
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mechanisms regulating PD-L1 expression in cancers and associated opportunities for novel small-molecule therapeutics
- (2022) Hirohito Yamaguchi et al. Nature Reviews Clinical Oncology
- LSD1 deletion decreases exosomal PD-L1 and restores T-cell response in gastric cancer
- (2022) Dan-Dan Shen et al. Molecular Cancer
- B7-H4 Immune Checkpoint Protein Affects Viability and Targeted Therapy of Renal Cancer Cells
- (2022) Maite Emaldi et al. Cells
- Revolutionization in Cancer Therapeutics via Targeting Major Immune Checkpoints PD-1, PD-L1 and CTLA-4
- (2022) Pratibha Pandey et al. Pharmaceuticals
- Regulation of PD-L1 expression in the tumor microenvironment
- (2021) Ming Yi et al. Journal of Hematology & Oncology
- Peptide Blocking CTLA-4 and B7-1 Interaction
- (2021) Stepan V. Podlesnykh et al. MOLECULES
- Beyond T-Cells: Functional Characterization of CTLA-4 Expression in Immune and Non-Immune Cell Types
- (2021) Damilola Oyewole-Said et al. Frontiers in Immunology
- Gastrointestinal toxicities associated with immune checkpoint inhibitors: a disproportionality analysis leveraging VigiBase, the WHO Adverse Drug Reaction Database
- (2021) Sifu Huang et al. Journal of Zhejiang University-SCIENCE B
- Evaluation of TMB as a predictive biomarker in patients with solid cancers treated with anti-PD-1/CTLA-4 combination immunotherapy
- (2021) Oliver Klein et al. CANCER CELL
- Energy status dictates PD-L1 protein abundance and anti-tumor immunity to enable checkpoint blockade
- (2021) Xiaoming Dai et al. MOLECULAR CELL
- LSD1 silencing contributes to enhanced efficacy of anti-CD47/PD-L1 immunotherapy in cervical cancer
- (2021) Shengjie Xu et al. Cell Death & Disease
- ARIH1 signaling promotes anti-tumor immunity by targeting PD-L1 for proteasomal degradation
- (2021) Youqian Wu et al. Nature Communications
- Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma
- (2021) Wei Guo et al. Frontiers in Immunology
- Targeting DNA Damage Repair for Immune Checkpoint Inhibition: Mechanisms and Potential Clinical Applications
- (2021) Wei Sun et al. Frontiers in Oncology
- M6A Demethylase ALKBH5 Regulates PD-L1 Expression and Tumor Immunoenvironment in Intrahepatic Cholangiocarcinoma
- (2021) Xinyao Qiu et al. CANCER RESEARCH
- Mechanism of action of PD‐1 receptor/ligand targeted cancer immunotherapy
- (2021) Jannie Borst et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Knockdown of CDK5 down-regulates PD-L1 via the ubiquitination-proteasome pathway and improves antitumor immunity in lung adenocarcinoma
- (2021) Lin Gao et al. Translational Oncology
- Top 10 Challenges in Cancer Immunotherapy
- (2020) Priti S. Hegde et al. IMMUNITY
- Neoadjuvant checkpoint blockade for cancer immunotherapy
- (2020) Suzanne L. Topalian et al. SCIENCE
- Decitabine Augments Chemotherapy-Induced PD-L1 Upregulation for PD-L1 Blockade in Colorectal Cancer
- (2020) Kevin Chih-Yang Huang et al. Cancers
- Small molecule inhibitors targeting the PD-1/PD-L1 signaling pathway
- (2020) Qian Wu et al. ACTA PHARMACOLOGICA SINICA
- Cancer immunotherapy: Pros, cons and beyond
- (2020) Shuzhen Tan et al. BIOMEDICINE & PHARMACOTHERAPY
- The landscape of CD28, CD80, CD86, CTLA4, and ICOS DNA methylation in head and neck squamous cell carcinomas
- (2020) Luka de Vos et al. Epigenetics
- Epigenetically silenced PD-L1 confers drug resistance to anti-PD1 therapy in gastric cardia adenocarcinoma
- (2020) Tianyu Zhu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Potential Therapeutic Targets of B7 Family in Colorectal Cancer
- (2020) Changgang Wang et al. Frontiers in Immunology
- The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
- (2020) Yuanyuan Zhang et al. Cellular & Molecular Immunology
- CDK7 inhibitor THZ1 enhances antiPD-1 therapy efficacy via the p38α/MYC/PD-L1 signaling in non-small cell lung cancer
- (2020) Jian Wang et al. Journal of Hematology & Oncology
- A decade of immune-checkpoint inhibitors in cancer therapy
- (2020) Caroline Robert Nature Communications
- IL-6 promotes PD-L1 expression in monocytes and macrophages by decreasing protein tyrosine phosphatase receptor type O expression in human hepatocellular carcinoma
- (2020) Wenjie Zhang et al. Journal for ImmunoTherapy of Cancer
- Immunomodulatory role for MicroRNAs: Regulation of PD-1/PD-L1 and CTLA-4 immune checkpoints expression
- (2020) Najwa Skafi et al. GENE
- β-Catenin induces transcriptional expression of PD-L1 to promote glioblastoma immune evasion
- (2020) Linyong Du et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The MAPK and AMPK signalings: interplay and implication in targeted cancer therapy
- (2020) Jimin Yuan et al. Journal of Hematology & Oncology
- Acetylation-dependent regulation of PD-L1 nuclear translocation dictates the efficacy of anti-PD-1 immunotherapy
- (2020) Yang Gao et al. NATURE CELL BIOLOGY
- PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis
- (2020) Junwei Hou et al. NATURE CELL BIOLOGY
- Deubiquitinating enzyme OTUB1 promotes cancer cell immunosuppression via preventing ER-associated degradation of immune checkpoint protein PD-L1
- (2020) Dan Zhu et al. CELL DEATH AND DIFFERENTIATION
- TFH cells depend on Tcf1-intrinsic HDAC activity to suppress CTLA4 and guard B-cell help function
- (2020) Fengyin Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PD-L1 Expression in Human Breast Cancer Stem Cells Is Epigenetically Regulated through Posttranslational Histone Modifications
- (2019) Pramod Darvin et al. Journal of Oncology
- Synergistic inhibition of pancreatic cancer with anti-PD-L1 and c-Myc inhibitor JQ1
- (2019) Yu Pan et al. OncoImmunology
- microRNA-148a-3p regulates immunosuppression in DNA mismatch repair-deficient colorectal cancer by targeting PD-L1
- (2019) Mai Ashizawa et al. MOLECULAR CANCER RESEARCH
- S100A9-induced overexpression of PD-1/PD-L1 contributes to ineffective hematopoiesis in myelodysplastic syndromes
- (2019) Pinyang Cheng et al. LEUKEMIA
- MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1
- (2019) Hui Li et al. GASTROENTEROLOGY
- Glioblastoma-Derived IL-6 Induces Immunosuppressive Peripheral Myeloid Cell PD-L1 and Promotes Tumor Growth
- (2019) Jonathan B Lamano et al. CLINICAL CANCER RESEARCH
- Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours
- (2019) Han Yao et al. Nature Biomedical Engineering
- B7-H3 immune checkpoint protein in human cancer
- (2019) Karine Flem-Karlsen et al. CURRENT MEDICINAL CHEMISTRY
- A multicenter, phase II study of soluble LAG-3 (Eftilagimod alpha) in combination with pembrolizumab (TACTI-002) in patients with advanced non-small cell lung cancer (NSCLC) or head and neck squamous cell carcinoma (HNSCC).
- (2019) Julio Antonio Peguero et al. JOURNAL OF CLINICAL ONCOLOGY
- MAPK pathway activity plays a key role in PD‐L1 expression of lung adenocarcinoma cells
- (2019) Thijs S Stutvoet et al. JOURNAL OF PATHOLOGY
- Targeting DNA Methylation and EZH2 Activity to Overcome Melanoma Resistance to Immunotherapy
- (2019) Abdullah Al Emran et al. TRENDS IN IMMUNOLOGY
- MicroRNA‐487a‐3p functions as a new tumor suppressor in prostate cancer by targeting CCND1
- (2019) Mingming Wang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion
- (2019) Li-Chuan Chan et al. JOURNAL OF CLINICAL INVESTIGATION
- Combination of CTLA-4 and PD-1 blockers for treatment of cancer
- (2019) Anand Rotte JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Lymphatic vasculature in tumor metastasis and immunobiology
- (2019) Xinguo Jiang Journal of Zhejiang University-SCIENCE B
- IRF1 Inhibits Antitumor Immunity through the Upregulation of PD-L1 in the Tumor Cell
- (2019) Lulu Shao et al. Cancer Immunology Research
- Prognostic Significance of Potential Immune Checkpoint Member HHLA2 in Human Tumors: A Comprehensive Analysis
- (2019) Ben Wang et al. Frontiers in Immunology
- MET Receptor Tyrosine Kinase Regulates the Expression of Co-Stimulatory and Co-Inhibitory Molecules in Tumor Cells and Contributes to PD-L1-Mediated Suppression of Immune Cell Function
- (2019) Hyun Kyung Ahn et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- PD-L1 expression is associated with ALK positivity and STAT3 activation, but not outcome in patients with systemic anaplastic large cell lymphoma
- (2019) Jing Shen et al. MODERN PATHOLOGY
- Crosstalk of intracellular post-translational modifications in cancer
- (2019) Zheng Wu et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- B7-H4, a promising target for immunotherapy
- (2019) Jia-Yu Wang et al. CELLULAR IMMUNOLOGY
- EGFR-TKI resistance promotes immune escape in lung cancer via increased PD-L1 expression
- (2019) Shunli Peng et al. Molecular Cancer
- MiR-214 prevents the progression of diffuse large B-cell lymphoma by targeting PD-L1
- (2019) Jing-Ran Sun et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- TIGIT as an emerging immune checkpoint
- (2019) H. Harjunpää et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- KYA1797K down-regulates PD-L1 in colon cancer stem cells to block immune evasion by suppressing the β-catenin/STT3 signaling pathway
- (2019) Zhiyan Ruan et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- MicroRNAs in tumor immunity: functional regulation in tumor-associated macrophages
- (2019) Chong Chen et al. Journal of Zhejiang University-SCIENCE B
- Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1
- (2018) Chia-Wei Li et al. CANCER CELL
- The Hippo Pathway Component TAZ Promotes Immune Evasion in Human Cancer through PD-L1
- (2018) Helena J. Janse van Rensburg et al. CANCER RESEARCH
- MiR-140 Expression Regulates Cell Proliferation and Targets PD-L1 in NSCLC
- (2018) Wei-Bin Xie et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- JAK2 and PD-L1 Amplification Enhance the Dynamic Expression of PD-L1 in Triple-negative Breast Cancer
- (2018) Meixuan Chen et al. Clinical Breast Cancer
- Wide Expression and Significance of Alternative Immune Checkpoint Molecules, B7x and HHLA2, in PD-L1–Negative Human Lung Cancers
- (2018) Haiying Cheng et al. CLINICAL CANCER RESEARCH
- Epstein−Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomas
- (2018) Eleni Anastasiadou et al. LEUKEMIA
- Inhibition of IL-6-JAK/Stat3 signaling in castration-resistant prostate cancer cells enhances the NK cell-mediated cytotoxicity via alteration of PD-L1/NKG2D ligand levels
- (2018) LiJun Xu et al. Molecular Oncology
- Genetic, transcriptional and post-translational regulation of the programmed death protein ligand 1 in cancer: biology and clinical correlations
- (2018) Ioannis Zerdes et al. ONCOGENE
- Immune Checkpoint Blockade: The New Frontier in Cancer Treatment
- (2018) Jeffrey M. Clarke et al. Targeted Oncology
- Oncofetal gene SALL4 reactivation by hepatitis B virus counteracts miR-200c in PD-L1-induced T cell exhaustion
- (2018) Cheng Sun et al. Nature Communications
- STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion
- (2018) Jung-Mao Hsu et al. Nature Communications
- Correlation of MET gene amplification and TP53 mutation with PD-L1 expression in non-small cell lung cancer
- (2018) Maher Albitar et al. Oncotarget
- The Protein Expression of PDL1 Is Highly Correlated with Those of eIF2α and ATF4 in Lung Cancer
- (2018) Liang-Che Chang et al. DISEASE MARKERS
- VSIG-3 as a ligand of VISTA inhibits human T cell function
- (2018) Jinghua Wang et al. IMMUNOLOGY
- MicroRNA-497-5p down-regulation increases PD-L1 expression in clear cell renal cell carcinoma
- (2018) Fajun Qu et al. JOURNAL OF DRUG TARGETING
- Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1
- (2018) Jong-Ho Cha et al. MOLECULAR CELL
- Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
- (2018) Spencer C. Wei et al. Cancer Discovery
- Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3
- (2018) Jun Wang et al. CELL
- Palmitoylation stabilizes PD-L1 to promote breast tumor growth
- (2018) Yi Yang et al. CELL RESEARCH
- Translational control of tumor immune escape via the eIF4F–STAT1–PD-L1 axis in melanoma
- (2018) Michaël Cerezo et al. NATURE MEDICINE
- PD-L1 methylation regulates PD-L1 expression and is associated with melanoma survival
- (2018) Goran Micevic et al. Pigment Cell & Melanoma Research
- Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA
- (2017) Matthew A. Coelho et al. IMMUNITY
- Potential targeting of B7-H4 for the treatment of cancer
- (2017) Joseph R. Podojil et al. IMMUNOLOGICAL REVIEWS
- New checkpoints in cancer immunotherapy
- (2017) Ling Ni et al. IMMUNOLOGICAL REVIEWS
- STAT3 Induces Immunosuppression by Upregulating PD-1/PD-L1 in HNSCC
- (2017) L.L. Bu et al. JOURNAL OF DENTAL RESEARCH
- The MLL1-H3K4me3 Axis-Mediated PD-L1 Expression and Pancreatic Cancer Immune Evasion
- (2017) Chunwan Lu et al. JNCI-Journal of the National Cancer Institute
- PD-L1 is commonly expressed and transcriptionally regulated by STAT3 and MYC in ALK-negative anaplastic large-cell lymphoma
- (2017) V Atsaves et al. LEUKEMIA
- MYC expression correlates with PD-L1 expression in non-small cell lung cancer
- (2017) Eun Young Kim et al. LUNG CANCER
- Small-Molecule Sigma1 Modulator Induces Autophagic Degradation of PD-L1
- (2017) Christina M. Maher et al. MOLECULAR CANCER RESEARCH
- Identification of CMTM6 and CMTM4 as PD-L1 protein regulators
- (2017) Riccardo Mezzadra et al. NATURE
- Cyclin D–CDK4 kinase destabilizes PD-L1 via cullin 3–SPOP to control cancer immune surveillance
- (2017) Jinfang Zhang et al. NATURE
- CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity
- (2017) Marian L. Burr et al. NATURE
- BIN1 reverses PD-L1-mediated immune escape by inactivating the c-MYC and EGFR/MAPK signaling pathways in non-small cell lung cancer
- (2017) J Wang et al. ONCOGENE
- Helicobacter Pylori Promote B7-H1 Expression by Suppressing miR-152 and miR-200b in Gastric Cancer Cells
- (2017) Gengchen Xie et al. PLoS One
- Radiation alters PD-L1/NKG2D ligand levels in lung cancer cells and leads to immune escape from NK cell cytotoxicity via IL-6-MEK/Erk signaling pathway
- (2017) Ming Jing Shen et al. Oncotarget
- A regulatory role for the co-chaperone FKBP51s in PD-L1 expression in glioma
- (2017) Paolo D'Arrigo et al. Oncotarget
- PD-L1 promoter methylation mediates the resistance response to anti-PD-1 therapy in NSCLC patients with EGFR-TKI resistance
- (2017) Yan Zhang et al. Oncotarget
- PD-L1 (CD274) and PD-L2 (PDCD1LG2) promoter methylation is associated with HPV infection and transcriptional repression in head and neck squamous cell carcinomas
- (2017) Alina Franzen et al. Oncotarget
- Increased PD-L1 expression in erlotinib-resistant NSCLC cells with MET gene amplification is reversed upon MET-TKI treatment
- (2017) Christina Demuth et al. Oncotarget
- Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
- (2017) Angel Garcia-Diaz et al. Cell Reports
- Epigenetic modifications of the immune-checkpoint genes CTLA4 and PDCD1 in non-small cell lung cancer results in increased expression
- (2017) Sebastian Marwitz et al. Clinical Epigenetics
- The MLL1-H3K4me3 Axis-Mediated PD-L1 Expression and Pancreatic Cancer Immune Evasion
- (2017) Chunwan Lu et al. JNCI-Journal of the National Cancer Institute
- Temporally Distinct PD-L1 Expression by Tumor and Host Cells Contributes to Immune Escape
- (2017) Takuro Noguchi et al. Cancer Immunology Research
- A novel bifunctional anti-PD-L1/TGF-β Trap fusion protein (M7824) efficiently reverts mesenchymalization of human lung cancer cells
- (2017) Justin M. David et al. OncoImmunology
- Coinhibitory Pathways in Immunotherapy for Cancer
- (2016) Susanne H. Baumeister et al. Annual Review of Immunology
- Is H3K4me3 instructive for transcription activation?
- (2016) Françoise S. Howe et al. BIOESSAYS
- Deubiquitination and Stabilization of PD-L1 by CSN5
- (2016) Seung-Oe Lim et al. CANCER CELL
- miRNA-487a Promotes Proliferation and Metastasis in Hepatocellular Carcinoma
- (2016) Rui-Min Chang et al. CLINICAL CANCER RESEARCH
- EGFR Mutations and ALK Rearrangements Are Associated with Low Response Rates to PD-1 Pathway Blockade in Non-Small Cell Lung Cancer: A Retrospective Analysis
- (2016) J. F. Gainor et al. CLINICAL CANCER RESEARCH
- Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
- (2016) Ana C. Anderson et al. IMMUNITY
- TIGIT Enhances Antigen-Specific Th2 Recall Responses and Allergic Disease
- (2016) Evangelia Kourepini et al. JOURNAL OF IMMUNOLOGY
- Loss of Peripheral Protection in Pancreatic Islets by Proteolysis-Driven Impairment of VTCN1 (B7-H4) Presentation Is Associated with the Development of Autoimmune Diabetes
- (2016) Ilian A. Radichev et al. JOURNAL OF IMMUNOLOGY
- PD-L1 Is Upregulated by Simultaneous Amplification of the PD-L1 and JAK2 Genes in Non–Small Cell Lung Cancer
- (2016) Seiichi Ikeda et al. Journal of Thoracic Oncology
- Identification of genes differentially expressed in menstrual breakdown and repair
- (2016) Premila Paiva et al. MOLECULAR HUMAN REPRODUCTION
- Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
- (2016) Vassiliki A. Boussiotis NEW ENGLAND JOURNAL OF MEDICINE
- MYC regulates the antitumor immune response through CD47 and PD-L1
- (2016) S. C. Casey et al. SCIENCE
- Pathological -synuclein transmission initiated by binding lymphocyte-activation gene 3
- (2016) X. Mao et al. SCIENCE
- Cdk5 disruption attenuates tumor PD-L1 expression and promotes antitumor immunity
- (2016) R. D. Dorand et al. SCIENCE
- Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity
- (2016) Chia-Wei Li et al. Nature Communications
- miR-424(322) reverses chemoresistance via T-cell immune response activation by blocking the PD-L1 immune checkpoint
- (2016) Shaohua Xu et al. Nature Communications
- Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations
- (2016) Daniel Sanghoon Shin et al. Cancer Discovery
- PD-L1 (CD274) promoter methylation predicts survival in colorectal cancer patients
- (2016) Diane Goltz et al. OncoImmunology
- Control of PD-L1 Expression by Oncogenic Activation of the AKT–mTOR Pathway in Non–Small Cell Lung Cancer
- (2015) Kristin J. Lastwika et al. CANCER RESEARCH
- Tumor suppressor miR-34a targets PD-L1 and functions as a potential immunotherapeutic target in acute myeloid leukemia
- (2015) Xi Wang et al. CELLULAR SIGNALLING
- Induction of PD-L1 Expression by the EML4-ALK Oncoprotein and Downstream Signaling Pathways in Non-Small Cell Lung Cancer
- (2015) K. Ota et al. CLINICAL CANCER RESEARCH
- TIGIT and PD-1 impair tumor antigen–specific CD8+ T cells in melanoma patients
- (2015) Joe-Marc Chauvin et al. JOURNAL OF CLINICAL INVESTIGATION
- TIGIT predominantly regulates the immune response via regulatory T cells
- (2015) Sema Kurtulus et al. JOURNAL OF CLINICAL INVESTIGATION
- Divergent Phenotypes of Human Regulatory T Cells Expressing the Receptors TIGIT and CD226
- (2015) Christopher A. Fuhrman et al. JOURNAL OF IMMUNOLOGY
- An Anti-B7-H4 Antibody–Drug Conjugate for the Treatment of Breast Cancer
- (2015) Steven R. Leong et al. MOLECULAR PHARMACEUTICS
- Immune-checkpoint proteins VISTA and PD-1 nonredundantly regulate murine T-cell responses
- (2015) Jun Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Galectin-3 Shapes Antitumor Immune Responses by Suppressing CD8+ T Cells via LAG-3 and Inhibiting Expansion of Plasmacytoid Dendritic Cells
- (2015) T. Kouo et al. Cancer Immunology Research
- PD-1 expression on dendritic cells suppresses CD8+ T cell function and antitumor immunity
- (2015) Tong Seng Lim et al. OncoImmunology
- EML4-ALK enhances programmed cell death-ligand 1 expression in pulmonary adenocarcinoma via hypoxia-inducible factor (HIF)-1α and STAT3
- (2015) Jaemoon Koh et al. OncoImmunology
- The Immunoreceptor TIGIT Regulates Antitumor and Antiviral CD8 + T Cell Effector Function
- (2014) Robert J. Johnston et al. CANCER CELL
- Expression, Clinical Significance, and Receptor Identification of the Newest B7 Family Member HHLA2 Protein
- (2014) M. Janakiram et al. CLINICAL CANCER RESEARCH
- T-cell Immunoglobulin and ITIM Domain (TIGIT) Receptor/Poliovirus Receptor (PVR) Ligand Engagement Suppresses Interferon-γ Production of Natural Killer Cells via β-Arrestin 2-mediated Negative Signaling
- (2014) Man Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors
- (2014) Alena Gros et al. JOURNAL OF CLINICAL INVESTIGATION
- A microRNA profile of human CD8+ regulatory T cells and characterization of the effects of microRNAs on Treg cell-associated genes
- (2014) Fadi Jebbawi et al. Journal of Translational Medicine
- Synergistic effects of IL-4 and TNFα on the induction of B7-H1 in renal cell carcinoma cells inhibiting allogeneic T cell proliferation
- (2014) Dagmar Quandt et al. Journal of Translational Medicine
- Control of pathogenic effector T-cell activities in situ by PD-L1 expression on respiratory inflammatory dendritic cells during respiratory syncytial virus infection
- (2014) S Yao et al. Mucosal Immunology
- Serum B7-H4 expression is a significant prognostic indicator for patients with gastric cancer
- (2014) Hongbing Shi et al. World Journal of Surgical Oncology
- B7-H4 expression and its role in interleukin-2/interferon treatment of clear cell renal cell carcinoma
- (2014) YIPENG XU et al. Oncology Letters
- Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression
- (2014) Limo Chen et al. Nature Communications
- PD-L1 Expression in Triple-Negative Breast Cancer
- (2014) E. A. Mittendorf et al. Cancer Immunology Research
- Immune checkpoints in cancer clinical trials
- (2014) Elad Sharon et al. Chinese Journal of Cancer
- Novel Recombinant Human B7-H4 Antibodies Overcome Tumoral Immune Escape to Potentiate T-Cell Antitumor Responses
- (2013) D. Dangaj et al. CANCER RESEARCH
- A Mechanism of Hypoxia-Mediated Escape from Adaptive Immunity in Cancer Cells
- (2013) I. B. Barsoum et al. CANCER RESEARCH
- PD-L1 Expression Is Characteristic of a Subset of Aggressive B-cell Lymphomas and Virus-Associated Malignancies
- (2013) B. J. Chen et al. CLINICAL CANCER RESEARCH
- Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents
- (2013) H Yang et al. LEUKEMIA
- B7 family checkpoint regulators in immune regulation and disease
- (2013) Sabrina Ceeraz et al. TRENDS IN IMMUNOLOGY
- B7-H5 costimulates human T cells via CD28H
- (2013) Yuwen Zhu et al. Nature Communications
- Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors
- (2013) E. A. Akbay et al. Cancer Discovery
- Constitutive AP-1 Activity and EBV Infection Induce PD-L1 in Hodgkin Lymphomas and Posttransplant Lymphoproliferative Disorders: Implications for Targeted Therapy
- (2012) M. R. Green et al. CLINICAL CANCER RESEARCH
- The Activation of MAPK in Melanoma Cells Resistant to BRAF Inhibition Promotes PD-L1 Expression That Is Reversible by MEK and PI3K Inhibition
- (2012) X. Jiang et al. CLINICAL CANCER RESEARCH
- PD-1 is a novel regulator of human B-cell activation
- (2012) Marie-Laure Thibult et al. INTERNATIONAL IMMUNOLOGY
- TGF-β of lung cancer microenvironment upregulates B7H1 and GITRL expression in dendritic cells and is associated with regulatory T cell generation
- (2012) XIAO YAN NI et al. ONCOLOGY REPORTS
- PD-1 Expression on Natural Killer Cells and CD8+ T Cells During Chronic HIV-1 Infection
- (2012) Sonia Norris et al. VIRAL IMMUNOLOGY
- TNF-α and TGF-β Counter-Regulate PD-L1 Expression on Monocytes in Systemic Lupus Erythematosus
- (2012) Jing-Ni Ou et al. Scientific Reports
- Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape
- (2011) S.-R. Woo et al. CANCER RESEARCH
- Cutting Edge: A Monoclonal Antibody Specific for the Programmed Death-1 Homolog Prevents Graft-versus-Host Disease in Mouse Models
- (2011) D. B. Flies et al. JOURNAL OF IMMUNOLOGY
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- B7-H1 expression is regulated by MEK/ERK signaling pathway in anaplastic large cell lymphoma and Hodgkin lymphoma
- (2009) Ryo Yamamoto et al. CANCER SCIENCE
- B7-H3 is a potent inhibitor of human T-cell activation: No evidence for B7-H3 and TREML2 interaction
- (2009) Judith Leitner et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Oncogenic kinase NPM/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1)
- (2008) M. Marzec et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search